Literature DB >> 7609058

Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1.

E M Cantin1, D R Hinton, J Chen, H Openshaw.   

Abstract

This study was initiated to evaluate a role for gamma interferon (IFN-gamma) in herpes simplex virus type 1 (HSV-1) infection. At the acute stage of infection in mice, HSV-1 replication in trigeminal ganglia and brain stem tissue was modestly but consistently enhanced in mice from which IFN-gamma was by ablated monoclonal antibody treatment and in mice genetically lacking the IFN-gamma receptor (Rgko mice). As determined by reverse transcriptase PCR, IFN-gamma and tumor necrosis factor alpha transcripts were present in trigeminal ganglia during both acute and latent HSV-1 infection. CD4+ and CD8+ T cells were detected initially in trigeminal ganglia at day 5 after HSV-1 inoculation, and these cells persisted for 6 months into latency. The T cells were focused around morphologically normal neurons that showed no signs of active infection, but many of which expressed HSV-1 latency-associated transcripts. Secreted IFN-gamma was present up to 6 months into latency in areas of the T-cell infiltration. By 9 months into latency, both the T-cell infiltrate and IFN-gamma expression had cleared, although there remained a slight increase in macrophage levels in trigeminal ganglia. In HSV-1-infected brain stem tissue, T cells and IFN-gamma expression were present at 1 month but were gone by 6 months after infection. Our hypothesis is that the persistence of T cells and the sustained IFN-gamma expression occur in response to an HSV-1 antigen(s) in the nervous system. This hypothesis is consistent with a new model of HSV-1 latency which suggests that limited HSV-1 antigen expression occurs during latency (M. Kosz-Vnenchak, J. Jacobson, D.M. Coen, and D.M. Knipe, J. Virol. 67:5383-5393, 1993). We speculate that prolonged secretion of IFN-gamma during latency may modulate a reactivated HSV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609058      PMCID: PMC189304          DOI: 10.1128/JVI.69.8.4898-4905.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome.

Authors:  A M Deatly; J G Spivack; E Lavi; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

Authors:  J G Stevens; E K Wagner; G B Devi-Rao; M L Cook; L T Feldman
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

Review 3.  An inquiry into the mechanisms of herpes simplex virus latency.

Authors:  B Roizman; A E Sears
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

4.  T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection.

Authors:  B M Gebhardt; J M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-11       Impact factor: 4.799

5.  Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus.

Authors:  E Feduchi; M A Alonso; L Carrasco
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Specific effect of interferon on the herpes simplex virus type 1 transactivation event.

Authors:  P R De Stasio; M W Taylor
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.

Authors:  T P Leist; M Eppler; R M Zinkernagel
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

8.  Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection.

Authors:  G J Stanton; C Jordan; A Hart; H Heard; M P Langford; S Baron
Journal:  Microb Pathog       Date:  1987-09       Impact factor: 3.738

9.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

10.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  95 in total

1.  Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.

Authors:  J R Lokensgard; S Hu; W Sheng; M vanOijen; D Cox; M C Cheeran; P K Peterson
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

2.  Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.

Authors:  C G Murphy; W T Lucas; R E Means; S Czajak; C L Hale; J D Lifson; A Kaur; R P Johnson; D M Knipe; R C Desrosiers
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Human herpesviruses in the cornea.

Authors:  S B Kaye; K Baker; R Bonshek; H Maseruka; E Grinfeld; A Tullo; D L Easty; C A Hart
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

4.  Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection.

Authors:  Laura K Mackay; Linda Wakim; Catherine J van Vliet; Claerwen M Jones; Scott N Mueller; Oliver Bannard; Douglas T Fearon; William R Heath; Francis R Carbone
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

5.  Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.

Authors:  Gary D Luker; Julie L Prior; Jiling Song; Christina M Pica; David A Leib
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo.

Authors:  Patric Lundberg; Paula Welander; Xiao Han; Edouard Cantin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes.

Authors:  Dejan Milatovic; Yueli Zhang; Sandra J Olson; Kathleen S Montine; L Jackson Roberts; Jason D Morrow; Thomas J Montine; Terence S Dermody; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

8.  Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; B N Carriere; R L Hendricks
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens.

Authors:  Anna Lang; James D Brien; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2.

Authors:  Gregg N Milligan; Michael G Meador; Chin-Fun Chu; Christal G Young; Talitha L Martin; Nigel Bourne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.